What are ABCL share price targets?

Their ABCL share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $21.88 in the next year. This suggests a possible upside of 399.4% from the stock's current price. View analysts price targets for ABCL or view top-rated stocks among Wall Street analysts.

Should you buy abcellera biologics (ABCL) stock?

There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ABCL shares. View ABCL analyst ratings or view top-rated stocks. What is AbCellera Biologics' stock price target for 2024?

Should you buy ABCL (ABCL) in 2022?

In 2022, ABCL's revenue was $485.42 million, an increase of 29.38% compared to the previous year's $375.20 million. Earnings were $158.52 million, an increase of 3.29%. According to 8 analysts, the average rating for ABCL stock is "Strong Buy." The 12-month stock price forecast is $20.0, which is an increase of 310.68% from the latest price.

Is ABCL trading at a 41% Discount?

ABCL is trading at a 41% discount. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ABCL is a good fit for your portfolio.